Skyward Specialty Details $559M Apollo Acquisition Financials, Reveals Pro Forma Impact
Summary
Skyward Specialty filed an amended 8-K to include pro forma financial statements for its $559.1 million acquisition of Apollo Group Holdings, detailing the financial impact and funding structure.
Key Events
-
Acquisition Financials Disclosed
This amendment provides the financial details of the previously announced acquisition of Apollo Group Holdings Limited, valued at $559.1 million.
-
Funding Structure Revealed
The acquisition was funded by $371 million in cash, sourced from new unsecured senior delayed draw term loan facilities totaling $300 million and an existing credit agreement, alongside the issuance of 3,679,332 shares of common stock.
-
Pro Forma Net Income Reduction
Pro forma combined financial statements for the year ended December 31, 2025, show a $23.3 million reduction in net income compared to the sum of the standalone entities, reflecting integration costs or accounting adjustments.
-
Goodwill and Intangibles Recognized
The acquisition resulted in a preliminary allocation of $147.4 million to goodwill and $262 million to identifiable intangible assets, including syndicate capacity, trade name, and cover holder relationships.
Analysis
This 8-K/A provides the crucial financial details of Skyward Specialty's previously announced acquisition of Apollo Group Holdings Limited. The acquisition, valued at $559.1 million, was funded by $371 million in cash (from new debt facilities) and the issuance of 3.68 million shares. The pro forma financial statements reveal a significant increase in combined revenues and expenses, but also indicate a pro forma reduction in net income for the year ended December 31, 2025, compared to the sum of the standalone entities. This filing is important for investors to understand the full financial implications and the impact on the company's capital structure and profitability post-acquisition.
At the time of this filing, SKWD was trading at $44.80 on NASDAQ in the Finance sector, with a market capitalization of approximately $2B. The 52-week trading range was $42.45 to $65.05. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.